<p>Bamco Inc. NY 在最近向证券交易委员会的披露中表示，在第二季度将其在西方制药服务公司（NYSE:WST - 免费报告）的股份减少了 26.1%。该基金在此期间出售了 108,501 股后，持有 307,647 股该医疗器械供应商的股票。截至其最近的 SEC 文件，Bamco Inc. NY 持有西方制药服务公司约 0.43% 的股份，价值 67,313,000 美元。</p>
<ul>
<li>3 只具有分红增长空间的分红冠军</li>
</ul>
<p>其他机构投资者也对该公司的股份进行了增减。AQR 资本管理公司在第二季度将其在西方制药服务公司的股份增加了 2,295.6%。AQR 资本管理公司现在拥有 104,950 股该医疗器械供应商的股票，价值 22,963,000 美元，此前在上个季度又购买了 100,569 股。Darwin 财富管理公司在第二季度购买了西方制药服务公司的新股份，价值 75,000 美元。Worldquant Millennium Advisors LLC 在第二季度将其在西方制药服务公司的股份提高了 16.8%。Worldquant Millennium Advisors LLC 现在拥有 313,321 股该医疗器械供应商的股票，价值 68,555,000 美元，此前在上个季度又购买了 45,050 股。加拿大养老金计划投资委员会在第二季度将其在西方制药服务公司的股份增加了 5.3%。加拿大养老金计划投资委员会现在拥有 65,102 股该医疗器械供应商的股票，价值 14,244,000 美元，此前在上个季度又购买了 3,297 股。最后，Bayesian Capital Management LP 在第二季度购买了西方制药服务公司的新股份，价值约 1,291,000 美元。对冲基金和其他机构投资者持有该公司 93.90% 的股票。</p>
<h2>分析师评级上调和下调</h2>
<p>一些研究分析师最近对该股票进行了评论。KeyCorp 在 10 月 24 日的报告中将西方制药服务公司的目标股价从 325.00 美元提高至 350.00 美元，并给予该公司 “超配” 评级。Rothschild Redb 在 9 月 15 日的研究报告中将西方制药服务公司的评级提升至 “强力买入”。Weiss Ratings 在 10 月 14 日的研究报告中重新发布了对西方制药服务公司的 “持有（c）” 评级。摩根士丹利在 12 月 1 日的研究报告中开始覆盖西方制药服务公司。他们给予该公司 “等权重” 评级，并设定 285.00 美元的目标股价。最后，Rothschild &amp; Co Redburn 在 9 月 15 日的研究报告中开始覆盖西方制药服务公司的股票。他们设定了 “买入” 评级和 311.00 美元的目标价。两位股票研究分析师对该股票给予了强力买入评级，八位给予了买入评级，四位对该公司的股票给予了持有评级。根据 MarketBeat，该公司目前的平均评级为 “适度买入”，共识目标价为 342.20 美元。</p>
<ul>
<li>今年将推动 S&amp;P 500 表现的因素是什么？</li>
</ul>
<p><strong>阅读我们关于 WST 的最新报告</strong></p>
<h2>西方制药服务公司股票下跌 2.0%</h2>
<p>NYSE:WST 在周五开盘时为 267.03 美元。该公司的市值为 192.1 亿美元，市盈率为 39.56，市盈增长比率为 4.21，贝塔值为 1.17。西方制药服务公司过去 12 个月的最低价为 187.43 美元，最高价为 348.90 美元。该公司的流动比率为 2.87，速动比率为 2.18，债务股本比率为 0.07。该股票的 50 日简单移动平均线为 273.72 美元，200 日简单移动平均线为 249.87 美元。</p>
<ul>
<li>至少有 30 年分红增长的医疗保健股票</li>
</ul>
<p>西方制药服务公司（NYSE:WST - 获取免费报告）在 10 月 23 日发布了季度财报。该医疗器械供应商报告季度每股收益为 1.96 美元，超出市场共识预期的 1.67 美元，超出 0.29 美元。西方制药服务公司的净利润率为 16.29%，股本回报率为 18.16%。该公司季度收入为 8.046 亿美元，而市场共识预期为 7.8842 亿美元。去年同期，该公司每股收益为 1.85 美元。与去年同期相比，该公司的收入增长了 7.7%。西方制药服务公司已将其 2025 财年的指导目标设定为每股收益 7.060-7.110 美元。分析师预计西方制药服务公司将在当前年度发布每股收益 6.62 美元。</p>
<h2>西方制药服务公司宣布分红</h2>
<p>该公司最近还宣布了一项季度分红，将于 2 月 4 日（星期三）支付。1 月 28 日（星期三）的股东将获得每股 0.22 美元的分红。这代表着每年 0.88 美元的分红和 0.3% 的分红收益率。该分红的除息日期为 1 月 28 日（星期三）。西方制药服务公司的派息比率目前为 13.04%。</p>
<h2>关于西方制药服务公司</h2>
<p>（免费报告）</p>
<p>西方制药服务公司设计、制造和销售用于注射药物和医疗产品的封闭和输送系统，业务遍及美洲、欧洲、中东、非洲和亚太地区。它分为两个部门，专有产品和合同制造产品。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票比西方制药服务公司更好</li>
<li>恒生指数是什么？</li>
<li>Synopsys 看到乐观转变，因为 Ansys 整合推动增长</li>
<li>如何从价值投资中获利</li>
<li>你能给自己最好的假日礼物是什么？好市多股票</li>
<li>如何找到可以投资和交易的便士股票</li>
<li>为什么 Zscaler 股票在 30% 的抛售后可能准备反弹</li>
</ul>
<p><strong>想看看其他对 WST 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取西方制药服务公司（NYSE:WST - 免费报告）的最新 13F 文件和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdTVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdTVA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在西方制药服务公司吗？</h2>
<p>在考虑西方制药服务公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而西方制药服务公司并不在名单上。</p>
<p>虽然西方制药服务公司目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西氏医药服务

<p>Bamco Inc. NY 在第二季度减少了对西氏医药服务的持股比例，下降了 26.1%，出售了 108,501 股。该基金目前持有 307,647 股，价值 6730 万美元。其他机构投资者也调整了他们的持仓。分析师对 WST 的评级褒贬不一，普遍目标价为 342.20 美元。WST 的第三季度收益超出预期，每股收益为 1.96 美元，收入为 8.046 亿美元。公司宣布将于 2 月 4 日支付季度股息</p>

<p>Bamco Inc. NY cut its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 26.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 307,647 shares of the medical instruments supplier's stock after selling 108,501 shares during the period. Bamco Inc. NY owned approximately 0.43% of West Pharmaceutical Services worth $67,313,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Bamco Inc. NY 在最近向证券交易委员会的披露中表示，在第二季度将其在西方制药服务公司（NYSE:WST - 免费报告）的股份减少了 26.1%。该基金在此期间出售了 108,501 股后，持有 307,647 股该医疗器械供应商的股票。截至其最近的 SEC 文件，Bamco Inc. NY 持有西方制药服务公司约 0.43% 的股份，价值 67,313,000 美元。</p>
</div><ul>
<li>3 Dividend Champions with room for dividend growth</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只具有分红增长空间的分红冠军</li>
</ul>
</div><p>Other institutional investors have also added to or reduced their stakes in the company. AQR Capital Management LLC boosted its position in shares of West Pharmaceutical Services by 2,295.6% during the 2nd quarter. AQR Capital Management LLC now owns 104,950 shares of the medical instruments supplier's stock valued at $22,963,000 after acquiring an additional 100,569 shares during the last quarter. Darwin Wealth Management LLC purchased a new stake in West Pharmaceutical Services during the second quarter valued at $75,000. Worldquant Millennium Advisors LLC lifted its position in West Pharmaceutical Services by 16.8% during the second quarter. Worldquant Millennium Advisors LLC now owns 313,321 shares of the medical instruments supplier's stock valued at $68,555,000 after purchasing an additional 45,050 shares during the last quarter. Canada Pension Plan Investment Board grew its stake in shares of West Pharmaceutical Services by 5.3% in the 2nd quarter. Canada Pension Plan Investment Board now owns 65,102 shares of the medical instruments supplier's stock worth $14,244,000 after buying an additional 3,297 shares in the last quarter. Finally, Bayesian Capital Management LP bought a new stake in shares of West Pharmaceutical Services in the 2nd quarter worth about $1,291,000. Hedge funds and other institutional investors own 93.90% of the company's stock.</p>
<div class="lb-trans"><p>其他机构投资者也对该公司的股份进行了增减。AQR 资本管理公司在第二季度将其在西方制药服务公司的股份增加了 2,295.6%。AQR 资本管理公司现在拥有 104,950 股该医疗器械供应商的股票，价值 22,963,000 美元，此前在上个季度又购买了 100,569 股。Darwin 财富管理公司在第二季度购买了西方制药服务公司的新股份，价值 75,000 美元。Worldquant Millennium Advisors LLC 在第二季度将其在西方制药服务公司的股份提高了 16.8%。Worldquant Millennium Advisors LLC 现在拥有 313,321 股该医疗器械供应商的股票，价值 68,555,000 美元，此前在上个季度又购买了 45,050 股。加拿大养老金计划投资委员会在第二季度将其在西方制药服务公司的股份增加了 5.3%。加拿大养老金计划投资委员会现在拥有 65,102 股该医疗器械供应商的股票，价值 14,244,000 美元，此前在上个季度又购买了 3,297 股。最后，Bayesian Capital Management LP 在第二季度购买了西方制药服务公司的新股份，价值约 1,291,000 美元。对冲基金和其他机构投资者持有该公司 93.90% 的股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调和下调</h2>
</div><p>A number of research analysts recently commented on the stock. KeyCorp increased their price target on shares of West Pharmaceutical Services from $325.00 to $350.00 and gave the company an &#34;overweight&#34; rating in a report on Friday, October 24th. Rothschild Redb raised West Pharmaceutical Services to a &#34;strong-buy&#34; rating in a research note on Monday, September 15th. Weiss Ratings reissued a &#34;hold (c)&#34; rating on shares of West Pharmaceutical Services in a research report on Tuesday, October 14th. Morgan Stanley started coverage on West Pharmaceutical Services in a research report on Monday, December 1st. They issued an &#34;equal weight&#34; rating and a $285.00 price target for the company. Finally, Rothschild &amp; Co Redburn initiated coverage on shares of West Pharmaceutical Services in a research note on Monday, September 15th. They set a &#34;buy&#34; rating and a $311.00 price objective for the company. Two equities research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $342.20.</p>
<div class="lb-trans"><p>一些研究分析师最近对该股票进行了评论。KeyCorp 在 10 月 24 日的报告中将西方制药服务公司的目标股价从 325.00 美元提高至 350.00 美元，并给予该公司 “超配” 评级。Rothschild Redb 在 9 月 15 日的研究报告中将西方制药服务公司的评级提升至 “强力买入”。Weiss Ratings 在 10 月 14 日的研究报告中重新发布了对西方制药服务公司的 “持有（c）” 评级。摩根士丹利在 12 月 1 日的研究报告中开始覆盖西方制药服务公司。他们给予该公司 “等权重” 评级，并设定 285.00 美元的目标股价。最后，Rothschild &amp; Co Redburn 在 9 月 15 日的研究报告中开始覆盖西方制药服务公司的股票。他们设定了 “买入” 评级和 311.00 美元的目标价。两位股票研究分析师对该股票给予了强力买入评级，八位给予了买入评级，四位对该公司的股票给予了持有评级。根据 MarketBeat，该公司目前的平均评级为 “适度买入”，共识目标价为 342.20 美元。</p>
</div><ul>
<li>What Factors Will Drive S&amp;P 500 Performance This Year?</li>
</ul>
<div class="lb-trans"><ul>
<li>今年将推动 S&amp;P 500 表现的因素是什么？</li>
</ul>
</div><p><strong>Read Our Latest Report on WST</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 WST 的最新报告</strong></p>
</div><h2>West Pharmaceutical Services Stock Down 2.0%</h2>
<div class="lb-trans"><h2>西方制药服务公司股票下跌 2.0%</h2>
</div><p>NYSE:WST opened at $267.03 on Friday. The company has a market cap of $19.21 billion, a price-to-earnings ratio of 39.56, a price-to-earnings-growth ratio of 4.21 and a beta of 1.17. West Pharmaceutical Services, Inc. has a twelve month low of $187.43 and a twelve month high of $348.90. The company has a current ratio of 2.87, a quick ratio of 2.18 and a debt-to-equity ratio of 0.07. The stock has a fifty day simple moving average of $273.72 and a 200-day simple moving average of $249.87.</p>
<div class="lb-trans"><p>NYSE:WST 在周五开盘时为 267.03 美元。该公司的市值为 192.1 亿美元，市盈率为 39.56，市盈增长比率为 4.21，贝塔值为 1.17。西方制药服务公司过去 12 个月的最低价为 187.43 美元，最高价为 348.90 美元。该公司的流动比率为 2.87，速动比率为 2.18，债务股本比率为 0.07。该股票的 50 日简单移动平均线为 273.72 美元，200 日简单移动平均线为 249.87 美元。</p>
</div><ul>
<li>Healthcare Stocks With at Least 30 Years of Dividend Increases</li>
</ul>
<div class="lb-trans"><ul>
<li>至少有 30 年分红增长的医疗保健股票</li>
</ul>
</div><p>West Pharmaceutical Services (NYSE:WST - Get Free Report) last posted its quarterly earnings results on Thursday, October 23rd. The medical instruments supplier reported $1.96 EPS for the quarter, topping the consensus estimate of $1.67 by $0.29. West Pharmaceutical Services had a net margin of 16.29% and a return on equity of 18.16%. The company had revenue of $804.60 million for the quarter, compared to the consensus estimate of $788.42 million. During the same quarter last year, the firm posted $1.85 EPS. The firm's revenue was up 7.7% compared to the same quarter last year. West Pharmaceutical Services has set its FY 2025 guidance at 7.060-7.110 EPS. Analysts anticipate that West Pharmaceutical Services, Inc. will post 6.62 EPS for the current year.</p>
<div class="lb-trans"><p>西方制药服务公司（NYSE:WST - 获取免费报告）在 10 月 23 日发布了季度财报。该医疗器械供应商报告季度每股收益为 1.96 美元，超出市场共识预期的 1.67 美元，超出 0.29 美元。西方制药服务公司的净利润率为 16.29%，股本回报率为 18.16%。该公司季度收入为 8.046 亿美元，而市场共识预期为 7.8842 亿美元。去年同期，该公司每股收益为 1.85 美元。与去年同期相比，该公司的收入增长了 7.7%。西方制药服务公司已将其 2025 财年的指导目标设定为每股收益 7.060-7.110 美元。分析师预计西方制药服务公司将在当前年度发布每股收益 6.62 美元。</p>
</div><h2>West Pharmaceutical Services Announces Dividend</h2>
<div class="lb-trans"><h2>西方制药服务公司宣布分红</h2>
</div><p>The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 4th. Stockholders of record on Wednesday, January 28th will be paid a dividend of $0.22 per share. This represents a $0.88 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Wednesday, January 28th. West Pharmaceutical Services's payout ratio is currently 13.04%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 2 月 4 日（星期三）支付。1 月 28 日（星期三）的股东将获得每股 0.22 美元的分红。这代表着每年 0.88 美元的分红和 0.3% 的分红收益率。该分红的除息日期为 1 月 28 日（星期三）。西方制药服务公司的派息比率目前为 13.04%。</p>
</div><h2>About West Pharmaceutical Services</h2>
<div class="lb-trans"><h2>关于西方制药服务公司</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.</p>
<div class="lb-trans"><p>西方制药服务公司设计、制造和销售用于注射药物和医疗产品的封闭和输送系统，业务遍及美洲、欧洲、中东、非洲和亚太地区。它分为两个部门，专有产品和合同制造产品。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than West Pharmaceutical Services</li>
<li>What is the Hang Seng index?</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>How to Profit From Value Investing</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>How to find penny stocks to invest and trade</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票比西方制药服务公司更好</li>
<li>恒生指数是什么？</li>
<li>Synopsys 看到乐观转变，因为 Ansys 整合推动增长</li>
<li>如何从价值投资中获利</li>
<li>你能给自己最好的假日礼物是什么？好市多股票</li>
<li>如何找到可以投资和交易的便士股票</li>
<li>为什么 Zscaler 股票在 30% 的抛售后可能准备反弹</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding WST?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 WST 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取西方制药服务公司（NYSE:WST - 免费报告）的最新 13F 文件和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVdTVA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=WST"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in West Pharmaceutical Services Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在西方制药服务公司吗？</h2>
</div><p>Before you consider West Pharmaceutical Services, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑西方制药服务公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而西方制药服务公司并不在名单上。</p>
</div><p>While West Pharmaceutical Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然西方制药服务公司目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Bamco Inc. NY 出售了 108,501 股西氏医药服务公司（West Pharmaceutical Services, Inc.）的股票 $WST